• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
New Tool Lets You Search CDC Advisors’ Big Pharma Ties

New Tool Lets You Search CDC Advisors’ Big Pharma Ties

March 11, 2025
ELIZABETH LAWRENCE: Americans Want Illegals Out, Say ICE Goes Too Far

ELIZABETH LAWRENCE: Americans Want Illegals Out, Say ICE Goes Too Far

February 22, 2026
TRON SIMPSON: Ted Nugent Slams Ticketmaster’s Big-Business Price Controls

TRON SIMPSON: Ted Nugent Slams Ticketmaster’s Big-Business Price Controls

February 21, 2026
DAVID BLACKMON: Stellantis Pivots To Diesel – What That Means For Europe’s EV Future

DAVID BLACKMON: Stellantis Pivots To Diesel – What That Means For Europe’s EV Future

February 21, 2026
NY Cardinal Timothy Dolan Reveals How He ‘Was Ticked Off’ By Mamdani, JD Vance’s ‘Scurrilous’ Suggestion

NY Cardinal Timothy Dolan Reveals How He ‘Was Ticked Off’ By Mamdani, JD Vance’s ‘Scurrilous’ Suggestion

February 21, 2026
Trump Announces ‘Legally Tested’ Maximum Tariff Action Against Countries Accused Of ‘Ripping The US Off’

Trump Announces ‘Legally Tested’ Maximum Tariff Action Against Countries Accused Of ‘Ripping The US Off’

February 21, 2026
Reality Star Reveals Cancer Diagnosis, Issues Blunt Screening Warning

Reality Star Reveals Cancer Diagnosis, Issues Blunt Screening Warning

February 21, 2026
EXCLUSIVE: Mike Benz Says Trump Admin Has ‘Once-In-Generation’ Chance To Put Deep State On Defense Post-Epstein Files

EXCLUSIVE: Mike Benz Says Trump Admin Has ‘Once-In-Generation’ Chance To Put Deep State On Defense Post-Epstein Files

February 21, 2026
Sheriff Keeping Tight Grip on Guthrie Kidnapping Probe, Insider Claims

Sheriff Keeping Tight Grip on Guthrie Kidnapping Probe, Insider Claims

February 21, 2026
Mayweather Ends Retirement, Targets Record-Breaking Return

Mayweather Ends Retirement, Targets Record-Breaking Return

February 21, 2026
Ex-UConn Standout Convicted in $328M Medicare Genetic Testing Fraud

Ex-UConn Standout Convicted in $328M Medicare Genetic Testing Fraud

February 21, 2026
DEBBIE LESKO: The Road To True Election Integrity In America

DEBBIE LESKO: The Road To True Election Integrity In America

February 21, 2026
Conan O’Brien Recalls Final Night With Reiners Before Shocking Double Murder

Conan O’Brien Recalls Final Night With Reiners Before Shocking Double Murder

February 21, 2026
  • Donald Trump
  • Tariffs
  • Congress
  • Faith
  • Immigration
Sunday, February 22, 2026
  • Login
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls
No Result
View All Result
IJR
No Result
View All Result
Home News

New Tool Lets You Search CDC Advisors’ Big Pharma Ties

by Daily Caller News Foundation
March 11, 2025 at 1:20 pm
in News, Wire
249 5
0
New Tool Lets You Search CDC Advisors’ Big Pharma Ties
493
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

Daily Caller News Foundation

A new search tool unveiled Friday increases public access to information about the connections between advisors to the Centers for Disease Control and Prevention on vaccine policy and the pharmaceutical industry.

The Advisory Committee on Immunization Practices (ACIP) discusses epidemiological studies, weighs the benefits and side effects reported in clinical trials, and makes recommendations to the CDC on the routine vaccination schedules for children and adults. The ACIP’s recommendations inform which shots are reimbursed by health plans. In a bid to enhance transparency around the process, the Department of Health and Human Services (HHS) has enabled users to search which advisors reported potential conflicts of interest and recused themselves from casting a vote affecting a drugmaker they had ties to.

The new tool is consistent with pledges by HHS Secretary Robert F. Kennedy Jr. to restore trust and the nation’s health agencies lost during the pandemic through increased information.

“In alignment with HHS Secretary Kennedy’s commitment to radical transparency, CDC released a tool for Americans to easily access conflicts of interest for ACIP committee members,” a CDC spokesman said in an email. “Rather than conflicts of interest being buried within meeting minutes, this tool quickly provides the public with ACIP members’ conflicts of interest.”

The ACIP became a flashpoint for controversy during the COVID-19 pandemic, reenergizing concerns about payments advisors receive from the pharmaceutical industry.

Of the experts who have served on the ACIP from 2000 to 2024, 38 advisors reported potential conflicts of interest.

That number could amount to approximately one third of the individuals who have served on the ACIP since 2000, assuming the ACIP was always fully staffed and adjusting for the shifting number of maximum ACIP members spelled out in its charter over the years. But this percentage could be an underestimate. For example, ACIP currently only has 14 members of the maximum 19.

Reported connections between the advisors and pharma included a range of potential conflicts: honoraria for lectures, consulting fees, employment at academic institutions conducting studies with drugmakers, or direct collaboration with drugmakers on clinical trials.

Advisors are asked to disclose conflicts of interest at the beginning of each public meeting and prior to a vote, but were otherwise tricky to track before the new tool became available.

ACIP members are required to submit confidential financial disclosures annually and self-report conflicts of interest at the start of each meeting and vote. Conflicts of interest and perceived conflicts of interest are vetted by the CDC if necessary, according to the committee’s website. But special government employees receiving no salary are not required to make public financial disclosures.

Some scientists praised the ACIP tool.

“They are the gatekeepers. The vendors’ job is to bring products into the market. At the same time, the gatekeepers ensure the product’s safety, accuracy, and reliability before human use,” said Masfique Mehedi, associate professor of biomedical sciences at the University of North Dakota, in an email to the Daily Caller News Foundation.

By contrast, Paul Offit, director of the Vaccine Education Center and an attending physician at Children’s Hospital of Philadelphia, who served on the ACIP from 1998 to 2003, said in an interview with DCNF that the tool is reflective of Kennedy’s beliefs about the pharmaceutical industry and could decrease public trust in vaccines.

“It’s very easy to say Big Pharma is this monster capturing the FDA. I just don’t see that in the vaccine world,” Offit said.

All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].

Tags: DCNFinvestigative-groupU.S. News
Share197Tweet123
Daily Caller News Foundation

Daily Caller News Foundation

Advertisements

Top Stories June 10th
Top Stories June 7th
Top Stories June 6th
Top Stories June 3rd
Top Stories May 30th
Top Stories May 29th
Top Stories May 24th
Top Stories May 23rd
Top Stories May 21st
Top Stories May 17th

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls

    Copyright © 2024 IJR

Top Stories June 10th Top Stories June 7th Top Stories June 6th Top Stories June 3rd Top Stories May 30th Top Stories May 29th Top Stories May 24th Top Stories May 23rd Top Stories May 21st Top Stories May 17th